Safety and Immune Response to a Clade C DNA HIV Vaccine (Q66077714)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Safety and Immune Response to a Clade C DNA HIV Vaccine
clinical trial

    Statements

    HVTN111 (English)
    0 references
    A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DNA and of MF59-adjuvanted Clade C Env Protein, in Healthy, HIV-uninfected Adult Participants (English)
    0 references
    0 references
    0 references
    0 references
    21 June 2016
    0 references
    11 July 2018
    0 references
    132
    0 references
    18 year
    0 references
    40 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit